Towards understanding epithelial-mesenchymal transition: A proteomics perspective

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1794, Issue 9, 2009, Pages 1325-1331

  Mathias, Rommel A ^a,b   Simpson, Richard J ^a  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Epithelial mesenchymal transition; Mass spectrometry; Multiple reaction monitoring; Orbitrap; Proteomics; Systems biology

Indexed keywords

CALPAIN; COFILIN 1; FASCIN; FILAMIN A; LIPOCORTIN; TRANSFORMING GROWTH FACTOR BETA;

CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENESIS; CELL ADHESION; CELL LYSATE; CELL MIGRATION; CYTOSKELETON; DOWN REGULATION; EPITHELIUM CELL; FIBROBLAST; HUMAN; LIQUID CHROMATOGRAPHY; LUNG ADENOCARCINOMA; MESENCHYME CELL; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS; REVIEW; SYSTEMS BIOLOGY; TANDEM MASS SPECTROMETRY;

ANIMALS; CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL CELLS; HUMANS; MESODERM; PROTEOMICS;

EID: 69349102421     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2009.05.001     Document Type: Review

References (54)

1. Thiery J.P., and Sleeman J.P. Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol. 7 (2006) 131-142
2. Yang J., and Weinberg R.A. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev. Cell 14 (2008) 818-829
3. Greenburg G., and Hay E.D. Epithelia suspended in collagen gels can lose polarity and express characteristics of migrating mesenchymal cells. J. Cell Biol. 95 (1982) 333-339
4. Lee J.M., Dedhar S., Kalluri R., and Thompson E.W. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J. Cell Biol. 172 (2006) 973-981
5. Stoker M., and Perryman M. An epithelial scatter factor released by embryo fibroblasts. J. Cell Sci. 77 (1985) 209-223
6. Weidner K.M., Behrens J., Vandekerckhove J., and Birchmeier W. Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells. J. Cell Biol. 111 (1990) 2097-2108
7. Gotzmann J., Mikula M., Eger A., Schulte-Hermann R., Foisner R., Beug H., and Mikulits W. Molecular aspects of epithelial cell plasticity: implications for local tumor invasion and metastasis. Mutat. Res. 566 (2004) 9-20
8. Guarino M., Rubino B., and Ballabio G. The role of epithelial-mesenchymal transition in cancer pathology. Pathology 39 (2007) 305-318
9. Huber M.A., Kraut N., and Beug H. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr. Opin. Cell Biol. 17 (2005) 548-558
10. Guarino M. Epithelial-mesenchymal transition and tumour invasion. Int. J. Biochem. Cell Biol. 39 (2007) 2153-2160
11. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2 (2002) 442-454
12. Cano A., Perez-Moreno M.A., Rodrigo I., Locascio A., Blanco M.J., del Barrio M.G., Portillo F., and Nieto M.A. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat. Cell Biol. 2 (2000) 76-83
13. Hajra K.M., Chen D.Y., and Fearon E.R. The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res. 62 (2002) 1613-1618
14. Eger A., Aigner K., Sonderegger S., Dampier B., Oehler S., Schreiber M., Berx G., Cano A., Beug H., and Foisner R. DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene 24 (2005) 2375-2385
15. Comijn J., Berx G., Vermassen P., Verschueren K., van Grunsven L., Bruyneel E., Mareel M., Huylebroeck D., and van Roy F. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol. Cell 7 (2001) 1267-1278
16. Perez-Moreno M.A., Locascio A., Rodrigo I., Dhondt G., Portillo F., Nieto M.A., and Cano A. A new role for E12/E47 in the repression of E-cadherin expression and epithelial-mesenchymal transitions. J. Biol. Chem. 276 (2001) 27424-27431
17. Hugo H., Ackland M.L., Blick T., Lawrence M.G., Clements J.A., Williams E.D., and Thompson E.W. Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J. Cell. Physiol. 213 (2007) 374-383
18. Zhang X., Wei D., Yap Y., Li L., Guo S., and Chen F. Mass spectrometry-based "omics" technologies in cancer diagnostics. Mass Spectrom. Rev. 26 (2007) 403-431
19. Hellman N.E., Spector J., Robinson J., Zuo X., Saunier S., Antignac C., Tobias J.W., and Lipschutz J.H. Matrix metalloproteinase 13 (MMP13) and tissue inhibitor of matrix metalloproteinase 1 (TIMP1), regulated by the MAPK pathway, are both necessary for Madin-Darby canine kidney tubulogenesis. J. Biol. Chem. 283 (2008) 4272-4282
20. Jechlinger M., Grunert S., Tamir I.H., Janda E., Ludemann S., Waerner T., Seither P., Weith A., Beug H., and Kraut N. Expression profiling of epithelial plasticity in tumor progression. Oncogene 22 (2003) 7155-7169
21. Yang J., Mani S.A., Donaher J.L., Ramaswamy S., Itzykson R.A., Come C., Savagner P., Gitelman I., Richardson A., and Weinberg R.A. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117 (2004) 927-939
22. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 136 (2009) 215-233
23. Gregory P.A., Bracken C.P., Bert A.G., and Goodall G.J. MicroRNAs as regulators of epithelial-mesenchymal transition. Cell Cycle 7 (2008) 3112-3118
24. Moreira J.M., Gromov P., and Celis J.E. Expression of the tumor suppressor protein 14-3-3 sigma is down-regulated in invasive transitional cell carcinomas of the urinary bladder undergoing epithelial-to-mesenchymal transition. Mol. Cell. Proteomics 3 (2004) 410-419
25. Willipinski-Stapelfeldt B., Riethdorf S., Assmann V., Woelfle U., Rau T., Sauter G., Heukeshoven J., and Pantel K. Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells. Clin. Cancer Res. 11 (2005) 8006-8014
26. Zhou C., Nitschke A.M., Xiong W., Zhang Q., Tang Y., Bloch M., Elliott S., Zhu Y., Bazzone L., Yu D., Weldon C.B., Schiff R., McLachlan J.A., Beckman B.S., Wiese T.E., Nephew K.P., Shan B., Burow M.E., and Wang G. Proteomic analysis of tumor necrosis factor-alpha resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotype. Breast Cancer Res. 10 (2008) R105
27. Cai Z., Zhou Y., Lei T., Chiu J.F., and He Q.Y. Mammary serine protease inhibitor inhibits epithelial growth factor-induced epithelial-mesenchymal transition of esophageal carcinoma cells. Cancer 115 (2009) 36-48
28. Wei J., Xu G., Wu M., Zhang Y., Li Q., Liu P., Zhu T., Song A., Zhao L., Han Z., Chen G., Wang S., Meng L., Zhou J., Lu Y., and Ma D. Overexpression of vimentin contributes to prostate cancer invasion and metastasis via src regulation. Anticancer Res. 28 (2008) 327-334
29. Keshamouni V.G., Jagtap P., Michailidis G., Strahler J.R., Kuick R., Reka A.K., Papoulias P., Krishnapuram R., Srirangam A., Standiford T.J., Andrews P.C., and Omenn G.S. Temporal quantitative proteomics by iTRAQ 2D-LC-MS/MS and corresponding mRNA expression analysis identify post-transcriptional modulation of actin-cytoskeleton regulators during TGF-beta-induced epithelial-mesenchymal transition. J. Proteome Res. 8 (2009) 35-47
30. Keshamouni V.G., Michailidis G., Grasso C.S., Anthwal S., Strahler J.R., Walker A., Arenberg D.A., Reddy R.C., Akulapalli S., Thannickal V.J., Standiford T.J., Andrews P.C., and Omenn G.S. Differential protein expression profiling by iTRAQ-2DLC-MS/MS of lung cancer cells undergoing epithelial-mesenchymal transition reveals a migratory/invasive phenotype. J. Proteome Res. 5 (2006) 1143-1154
31. Ross P.L., Huang Y.N., Marchese J.N., Williamson B., Parker K., Hattan S., Khainovski N., Pillai S., Dey S., Daniels S., Purkayastha S., Juhasz P., Martin S., Bartlet-Jones M., He F., Jacobson A., and Pappin D.J. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell. Proteomics 3 (2004) 1154-1169
32. Sheehan K.M., Gulmann C., Eichler G.S., Weinstein J.N., Barrett H.L., Kay E.W., Conroy R.M., Liotta L.A., and Petricoin E.F. Signal pathway profiling of epithelial and stromal compartments of colonic carcinoma reveals epithelial-mesenchymal transition. Oncogene 27 (2008) 323-331
33. Hill J.J., Tremblay T.L., Cantin C., O'Connor-McCourt M., Kelly J.F., and Lenferink A.E. Glycoproteomic analysis of two mouse mammary cell lines during transforming growth factor (TGF)-beta induced epithelial to mesenchymal transition. Proteome Sci. 7 (2009) 2
34. Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D., Brush J., Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P., Eaton D., Foster J., Grimaldi C., Gu Q., Hass P.E., Heldens S., Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., Lewis L., Liao D., Mark M., Robbie E., Sanchez C., Schoenfeld J., Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A., Vandlen R., Watanabe C., Wieand D., Woods K., Xie M.H., Yansura D., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A., Wood W.I., Godowski P., and Gray A. The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment. Genome Res. 13 (2003) 2265-2270
35. Prudovsky I., Tarantini F., Landriscina M., Neivandt D., Soldi R., Kirov A., Small D., Kathir K.M., Rajalingam D., and Kumar T.K. Secretion without Golgi. J. Cell. Biochem. 103 (2008) 1327-1343
36. Simpson R.J., Jensen S.S., and Lim J.W. Proteomic profiling of exosomes: current perspectives. Proteomics 8 (2008) 4083-4099
37. Ji H., Erfani N., Tauro B.J., Kapp E.A., Zhu H.J., Moritz R.L., Lim J.W., and Simpson R.J. Difference gel electrophoresis analysis of Ras-transformed fibroblast cell-derived exosomes. Electrophoresis 29 (2008) 2660-2671
38. Iwadate Y. Clinical proteomics in cancer research-promises and limitations of current two-dimensional gel electrophoresis. Curr. Med. Chem. 15 (2008) 2393-2400
39. Stasyk T., and Huber L.A. Zooming in: fractionation strategies in proteomics. Proteomics 4 (2004) 3704-3716
40. Brunet S., Thibault P., Gagnon E., Kearney P., Bergeron J.J., and Desjardins M. Organelle proteomics: looking at less to see more. Trends Cell Biol. 13 (2003) 629-638
41. Yates J.R., Gilchrist A., Howell K.E., and Bergeron J.J. Proteomics of organelles and large cellular structures. Nat. Rev. Mol. Cell Biol. 6 (2005) 702-714
42. Han X., Aslanian A., and Yates III J.R. Mass spectrometry for proteomics. Curr. Opin. Chem. Biol. 12 (2008) 483-490
43. Hu Q., Noll R.J., Li H., Makarov A., Hardman M., and Graham Cooks R. The Orbitrap: a new mass spectrometer. J. Mass Spectrom. 40 (2005) 430-443
44. Perry R.H., Cooks R.G., and Noll R.J. Orbitrap mass spectrometry: instrumentation, ion motion and applications. Mass Spectrom. Rev. 27 (2008) 661-699
45. Hanke S., Besir H., Oesterhelt D., and Mann M. Absolute SILAC for accurate quantitation of proteins in complex mixtures down to the attomole level. J. Proteome Res. 7 (2008) 1118-1130
46. N.R. Kitteringham, R.E. Jenkins, C.S. Lane, V.L. Elliott, B.K. Park, Multiple reaction monitoring for quantitative biomarker analysis in proteomics and metabolomics, J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877 (2009) 1229-1239.
47. Lange V., Picotti P., Domon B., and Aebersold R. Selected reaction monitoring for quantitative proteomics: a tutorial. Mol. Syst. Biol. 4 (2008) 222
48. Pisitkun T., Hoffert J.D., Yu M.J., and Knepper M.A. Tandem mass spectrometry in physiology. Physiology 22 (2007) 390-400
49. Wolf-Yadlin A., Hautaniemi S., Lauffenburger D.A., and White F.M. Multiple reaction monitoring for robust quantitative proteomic analysis of cellular signaling networks. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 5860-5865
50. Hood L. Systems biology: integrating technology, biology, and computation. Mech. Ageing Dev. 124 (2003) 9-16
51. Rho S., You S., Kim Y., and Hwang D. From proteomics toward systems biology: integration of different types of proteomics data into network models. BMP Rep. 41 (2008) 184-193
52. Armstrong J.D., Pocklington A.J., Cumiskey M.A., and Grant S.G. Reconstructing protein complexes: from proteomics to systems biology. Proteomics 6 (2006) 4724-4731
53. Au C.E., Bell A.W., Gilchrist A., Hiding J., Nilsson T., and Bergeron J.J. Organellar proteomics to create the cell map. Curr. Opin. Cell Biol. 19 (2007) 376-385
54. R. Mathias, B. Wang, H. Ji, E. Kapp, R. Moritz, H.J. Zhu, R. Simpson, Secretome-based proteomic profiling of Ras-transformed MDCK cells reveals extracellular modulators of epithelial-mesenchymal transition, J. Proteome Res. (in press), doi:10.1021/pr8010974.